NOTE 13 - NET LOSS PER SHARE:

The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented (USD in thousands, except per share data):

	Year ended December 31
	2024		2023
Numerator:
Net loss for the year	$	16,519	$	5,108
Net loss attributable to ordinary shareholders:
Basic and diluted	$	16,443	$	4,942
Denominator:
Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted		623,846		111,726

Net loss per share attributable to ordinary shareholders, basic and diluted	$	26.36	$	44.23

Basic loss per share is computed on the basis of the net loss for the period divided by the weighted average number of ordinary shares outstanding during the period, and fully vested pre-funded options for the Company’s (or Silexion’s, as applicable) ordinary shares at an exercise price of $0.0226 or 0.0226 NIS per share, as the Company (or Silexion, as applicable) considers these shares to be exercised for little to no additional consideration.

As of December 31, 2024 and 2023, the basic loss per share calculation included a weighted average number of 2,081 and 14,652, respectively, fully vested pre-funded options.

The following instruments were not included in the computation of diluted earnings per share because of their anti-dilutive effect:

Redeemable convertible preferred shares (see Note 9);

Warrants to purchase redeemable convertible preferred shares (see Note 8);

Share-based compensation issuable for substantial consideration (see Note 11);

Warrants to purchase ordinary shares (which were originally SPAC warrants (see Note 3));

Underwriters Promissory Note and Related Party Promissory Note (see Note 3);

ELOC financing (see Note 3);

As such, diluted net loss per share is the same as basic net loss per share.